Showing 1,272 results

Filters Content type: News, Editors' picks Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

New & experimental HIV treatments

European CHMP Adopts Positive Opinion for Gilead’s Biktarvy® (Bictegravir, Emtricitabine, Tenofovir Alafenamide)

Editor's pick
Gilead press release
27 April 2018
Side effects

TAF only superior to TDF when used with a boosting agent

News
10 April 2018
Treatment guidelines

U.S. Guidelines Panel Strongly Recommends Gilead’s HIV Regimen Biktarvy

Editor's pick
Poz
4 April 2018
Pharmaceutical industry

A Cheaper Version of Truvada Is Hitting the US Market: Here's Why It Might Not Lower Costs

Editor's pick
The Body
4 April 2018
Pharmaceutical industry

Mylan Introduces Symfi™ Triple Combo Once-Daily HIV Treatment in the U.S.

Editor's pick
Mylan press release
3 April 2018
New & experimental HIV treatments

Ibalizumab-uiyk for HIV: What Pharmacists Should Know

Editor's pick
Pharmacy Times
27 March 2018
New & experimental HIV treatments

ViiV Healthcare gains CHMP Positive Opinion for Juluca (dolutegravir/rilpivirine) in Europe

Editor's pick
ViiV press release
23 March 2018
New & experimental HIV treatments

Powerful new PrEP and treatment drug should be effective as a small weekly pill

News
12 March 2018
New & experimental HIV treatments

Ibalizumab, active against highly resistant HIV, now approved in US

News
8 March 2018
People with limited treatment options

FDA approves new HIV treatment for patients who have limited treatment options

Editor's pick
FDA
7 March 2018
Changing treatment

Biktarvy combo maintains viral suppression after switching therapy

News
7 March 2018
The search for a cure

Experimental antibody plus TLR7 agonist maintains viral suppression in monkeys

News
5 March 2018
New & experimental HIV treatments

CytoDyn Reports Primary Endpoint Achieved in PRO 140 Pivotal Combination Therapy Trial in HIV Infection

Editor's pick
CytoDyn press release
21 February 2018
New & experimental HIV treatments

Mylan (MYL) Announces Tentative Approval for Combination HIV Treatment DTG/FTC/TAF Under FDA's PEPFAR Program

Editor's pick
Mylan press release
20 February 2018
New & experimental HIV treatments

US regulators approve new HIV combo pill containing bictegravir

News
8 February 2018
New & experimental HIV treatments

ViiV Healthcare launches eighth phase III study in two-drug regimen programme for HIV-1 treatment

Editor's pick
ViiV press release
8 February 2018
New & experimental HIV treatments

US FDA approves Gilead triple HIV drug, rival files lawsuit

Editor's pick
Reuters
8 February 2018
Injectable & long-acting PrEP

Long-acting injectable ARVs are convenient and private, study participants report

News
17 January 2018
Pharmaceutical industry

Teva Announces Exclusive Launch of a Generic Version of Reyataz® in the United States

Editor's pick
Teva press release
10 January 2018
Injectable & long-acting HIV treatment

New 'mini-pillbox' device could deliver three HIV drugs in a single once-weekly dose

News
9 January 2018
New & experimental HIV treatments

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

Editor's pick
Yale News
8 January 2018
New & experimental HIV treatments

FDA Accepts New Drug Applications for Merck’s Doravirine, the Company’s Investigational Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), for Treatment of HIV-1 Infection

Editor's pick
Merck press release
8 January 2018
New & experimental HIV treatments

HIV Drugs in the Pipeline: Expected Approvals for 2018

Editor's pick
Infectious Disease Special Edition
31 December 2017
New & experimental HIV treatments

Dolutegravir and lamivudine potent and safe in people starting HIV therapy for the first time

News
28 December 2017